Education

Timely Topics in Transplantation

Timely Topics in Transplantation webinars are the perfect opportunity to listen to a live presentation on a current issue and ask questions directly to the presenter. All webinars are available on demand after the live air date. 

How to Register for an Individual Webinar
Pre-registration is required for each webinar in order to receive reminders and access instructions on the day of the webinar. Click "Register" under any webinar below and you will be taken to the AST digital library website. On that website, click the "Register" link to add the webinar to your cart and proceed to checkout.

AST MEMBERS: To remove the $25 fee, simply log in with your AST username and password and the charge will change to $0.
NON-MEMBERS: If you have an account on the AST website, sign in with those credentials. If you do not have an account with AST, create an account and proceed with the purchase (your account will not be an AST website account nor a membership account; it is your webinar access account).

Epitope Matching in Kidney Allocation

Wednesday, September 27, 2017 - 2:00 pm to 3:00 pm EDT

Register

Speaker: Massimo Mangiola, PhD • University of Pittsburgh Medical Center
Moderator: Julie Yabu, MD • UCLA

After participating in this webinar, the learner will be able to:

  1. Describe epitopes in the context of transplantation.
  2. Discuss the importance of epitopes in HLA compatiblity and optimizing graft outcome.
  3. Summarize how to potentially use "epitope tools" in HLA antibody analysis and matching of donors and recipients pairs.

Evaluation and Management of a Failing Allograft

Tuesday, October 17, 2017 - 2:00 pm to 3:00 pm EDT

Register

Speaker: Martha Pavlakis, MD • Beth Israel Deaconess Medical Center
Moderator: Tarek Alhamad, MD • Washington University School of Medicine in St. Louis

Novel Immunosuppressants: Applicability to Thoracic Organ Transplantation?

Tuesday, November 14, 2017 - 2:00 pm to 3:00 pm EST

Register

Speaker: Jon Kobashigawa, MD • Cedars Sinai Heart Institute
Moderator: Sean Pinney, MD • Mount Sinai School of Medicine

Invasive Fungal Diseases – Emerging Diagnostics and New Therapies

Tuesday, December 5, 2017 - 2:00 pm to 3:00 pm EST

Register

Speaker: Francisco Marty, MD • Brigham and Women's Hospital
Moderator: Leonardo Riella, MD, PhD, FASN, FAST • Brigham and Women's Hospital

Improving Rigor and Reproducibility in Animal Models

Wednesday, January 17, 2018 - 2:00 pm to 3:00 pm EST

Register

Speaker: Ronald Gill, PhD • University of Colorado - Denver
Moderator: Leonardo Riella, MD, PhD, FASN, FAST • Brigham and Women's Hospital

Update in Vaccinations (Included in Both Pediatric and ID Educational Gaps)

Wednesday, February 21, 2018 - 2:00 pm to 3:00 pm EST

Register

Speaker: Lara Danziger-Isakov, MD, MPH • Cincinnati Children's Hospital Medical Center
Moderator: TBD

Change Management

Wednesday, March 21, 2018 - 2:00 pm to 3:00 pm EDT

Register

Speaker: Janie Oakley, MSPOD • Mayo Clinic
Moderator: TBD

Archived Webinars

Precision Medicine Approaches in Transplantation

Monday, December 12, 2016 - 2:00 pm to 3:00 pm EST

View Archive

Speaker: Minnie Sarwal, MD, PhD, MRCP, DCH, FRCP • University of California San Francisco
Moderator: Julie Yabu, MD • Stanford University
 

After participating in this webinar, the learner will be able to:

  1. Identify potential biomarkers and assays for diagnosis for rejection and graft injury
  2. Describe the integration of bioinformatics and datasets in transplantation
  3. Design a strategy to prospectively manage transplant patients using biomarkers to preserve organ function

Multi-drug-resistant Organisms

Thursday, November 17, 2016 - 3:00 pm EST

View Archive

Speaker: Stephanie Pouch, MD • The Ohio State University Medical Center
Moderator: Shirish Huprikar, MD • Icahn School of Medicine at Mount Sinai

Multidrug-resistant organisms (MDROs) pose a particular threat to solid organ transplant recipients.  Infections due to these pathogens are associated with significant morbidity and mortality, and current therapeutic options are limited.  

After participating in this webinar, the learner will be able to:

  1. Describe the epidemiology and outcomes of select MDRO infections in solid organ transplant recipients.
  2. Describe an approach to the use of organs from donors colonized or infected with CRE.
  3. Discuss the role of infection control and antimicrobial stewardship in curtailing the spread of MDROs in solid organ transplant recipients. 

Significance, Identification and Treatment of Post-thoracic Transplant Circulating Antibodies

Tuesday, November 15, 2016 - 2:00 pm to 3:00 pm EST

View Archive

Speaker: Jignesh Patel, MD • Cedars-Sinai Heart Institute
Moderator: Monica Colvin, MD, MS • University of Michigan

The presence of donor specific antibodies predisposes the thoracic allograft to the risk of antibody mediated rejection, chronic graft dysfunction and increased mortality. Optimal outcomes depend upon a comprehensive understanding of the significance of circulating antibodies after transplantation.  What are the best strategies for defining deleterious antibodies, what are the current available therapies to address these and how effective are they?
 

After participating in this webinar, the learner will be able to:
  1. Identify the significance of circulating antibodies in patients awaiting thoracic transplantation or in patients with development of de novo antibodies after transplantation.
  2. Order appropriate tests to detect relevant donor specific antibodies.
  3. Design rational therapies for the treatment of post-thoracic transplant circulating antibodies.

An Update on Current Concepts in Donor Specific Antibody Testing

Tuesday, October 18, 2016 - 2:00 pm to 3:00 pm EDT

VIEW ARCHIVE
 

Read the Q&A that wasn't answered during webinar

Speaker: Peter Nickerson, MD, FRCPC, FCAHS • University of Manitoba
Moderator: Leonardo Riella, MD, PhD • Harvard Medical School

After participating in this webinar, the learner will be able to:

  1. Understand the use and limitations of solid phase assays in identifying anti-HLA antibodies
  2. Describe the natural history and significance of DSA development post-transplant
  3. Discuss novel tools to improve specificity of solid phase assays 

Pediatric Re-transplantation: Who, When, and How to Ensure the Best Outcome

Tuesday, June 21, 2016 - 2:00 pm to 3:00 pm EDT

View Archive

Speaker: Robert Ettenger, MD • UCLA Center for Health Science
Moderator: Vikas Dharnidharka, MD • Washington University

After participating in this webinar, the learner will be able to:

  1. Understand the measures that can be taken before, during and after the first transplant to promote the success of the second transplant
  2. Identify the appropriate immunological, psychological,and technical steps that should be taken to help assure an optimal outcome
  3. Describe the peri- and post-transplant care, including immunosuppression, that are necessary to obtain the best results

Strategies to Improve Recipient Readiness and Reduce Disparities

Tuesday, May 17, 2016 - 2:00 pm to 3:00 pm EDT

View Archive
 

Read the Q&A that wasn't answered during webinar

Speaker: Rachel Patzer, PhD • Emory Universtiy
Moderator:
Leo Riella, MD, PhD • Harvard Medical School

Significant barriers exist that may prevent patients from successfully navigating the complex transplant process to receive a transplant, including referral for transplant evaluation, starting the transplant evaluation, and completing the steps necessary to be placed on the national deceased donor waiting list or receive a kidney transplantation.  There are several strategies and tools that transplant center physicians and staff members can use to improve patient access to transplantation and reduce disparities.

After participating in this webinar, the learner will be able to:

  1. Understand the key patient- and health system-related barriers in access to multiple steps of the transplantation process
  2. Evaluate the existing evidence-base of approaches for improving patient readiness and access to transplantation
  3. Identify potential solutions that transplant centers can implement to reduce disparities in transplantation access

Kidney Allocation System Update: Where Are We So Far?

Tuesday, April 19, 2016 - 2:00 pm to 3:00 pm EDT

View Archive

Speaker: Mark Aeder, MD • University Hospitals Case Medical Center
Moderator: Nicole Turgeon, MD •  Emory University

The Kidney Allocation System (KAS) was markedly revised on December 4, 2014, resulting in a major early alteration in national kidney distribution. Since a major objective was to provide equity in access to challenged candidates while not compromising vulnerable populations, and allowing for the bolus effects, this presentation will examine first year outcomes and assess the success in meeting the projected KAS goals.

After participating in this webinar, the learner will be able to:

  1. Identify the changes in kidney transplant distribution across recipient categories
  2. Distinguish the changes which will be maintained at a new level following the resolution of the initial bolus effect
  3. Begin to formulate potential modifications to KAS which would further achieve equity in allocation

Meeting Review: Cutting Edge of Transplantation: Solving the Organ Shortage

Tuesday, April 5, 2016 - 2:00 pm to 3:00 pm EDT

View Archive

Speaker: Richard Formica, MD • Yale University School of Medicine
Moderator: Anil Chandraker, MD, FRCP • Brigham & Women's Hospital

AST's Cutting Edge of Transplantation welcomed a record number of attendees to Phoenix February 25 - 27. During nearly 30 hours of sessions over three days, transplant professionals explored the history behind the organ shortage, what we are doing now to address the issues, and the direction we should take going forward. If you missed the meeting, this is your chance to understand the key highlights from CEOT. Dr. Formica will present the major takeaways, covering topics from allocation to organ utilization to policy to incentives/disincentives. This is a truly multidisciplinary webinar which will be useful to all transplant organ specialties. You may have missed CEOT but don't miss this highlights webinar.

What Makes for a Good Living Donor Program?

Tuesday, February 16, 2016 - 2:00 pm to 3:00 pm EST

View Archive

Speaker: Matt Cooper, MD • Medstar Georgetown Transplant Institute
Moderator: Harini Chakkera, MD • Mayo Clinic Hospital

After participating in this webinar, the learner will be able to:

  1. Define the components of a successful living donor kidney program to evaluate an efficient number of FTE’s and assistant personnel as well as developing and cultivating a culture within that personnel to best support living donors, their support staff, and their needs.
  2. Appraise the current resource allocation of their current living donor program and analyze where investments might be best undertaken to begin process improvements.
  3. Evaluate current living donor program metrics beyond number of potential donors and number of organs transplanted to work towards a more critical evaluation of measuring success in personnel activities as well as patient safety and program quality.

 

Management of Immunosuppression in the Setting of Acute Infectious Complications and Malignancy

Tuesday, January 26, 2016 - 2:00 pm to 3:00 pm EST

View Archive

Speaker: Daniel Brennan, MD • Washington University School of Medicine
Moderator: Robert Brown, MD • Weill Cornell Medical College

Optimal immunosuppression in organ transplantation is a balance between under immunosuppression, which is associated with graft rejection, and over immunosuppression, which is associated with infection and malignancy. Initial immunosuppression is designed to strike this balance. But how should one adjust immunosuppression when this balance is perturbed and there is an acute infectious complication or malignancy?

After participating in this webinar, the learner will be able to:

  1. Identify risks for development of acute infectious complications and malignancy in renal transplant recipients.
  2. Design rational immunosuppression strategies to manage acute infectious complications in renal transplant recipients.
  3. Design rational immunosuppression strategies to manage malignancy in renal transplant recipients.

Educational Content Disclaimer: The content, information, opinions, and viewpoints contained in educational materials housed on and linked from the AST web site are those of the authors or contributors of such materials. While the AST and its committees take great care to screen the credentials of the contributors and make every attempt to review the contents, AST MAKES NO WARRANTY, EXPRESSED OR IMPLIED, as to the completeness or accuracy of the content contained in the educational materials or on this website. The reader of these materials uses these materials at his or her own risk, and AST shall not be responsible for any errors, omissions, or inaccuracies in these materials, whether arising through negligence, oversight, or otherwise. Reliance on any information appearing on this site is strictly at your own risk. Read the full disclaimer.